Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric citrate vs sevelamer for lowering protein-bound uremic toxins in pre-dialysis CKD with hyperphosphatemia
TCTR20260306004Phase 3Completed
- Sponsor
- Thai Red Cross Society
- Start
- May 2025
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised trial in chronic kidney disease (CKD) and hyperphosphatemia comparing Ferric citrate with Sevelamer (2 arms). Started May 2025; status: completed.
02
Drugs
ferric citratesevelamer carbonate
03
Conditions
chronic kidney disease (CKD)hyperphosphatemia
Beyond the preview
Go deeper on TCTR20260306004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260306004.